Quote this publication Share Print

PENTHROX, methoxyflurane, anaesthetic for emergency analgesia

PAIN - New medicinal product
Opinions on drugs - Posted on Feb 02 2017

Reason for request

Inclusion

No clinical benefit demonstrated relative to other available analgesics

 

  • PENTHROX has Marketing Authorisation in the emergency relief of moderate to severe pain associated with trauma in conscious adult patients.
  • Its analgesic superiority compared with placebo has been demonstrated in a study in patients with predominantly moderate pain.
  • Its efficacy in case of very severe pain (NS > 7 or VAS > 70) has not been evaluated.
  • No comparison of satisfactory methodological quality with other analgesics is available.

 


Clinical Benefit

Moderate

No clinical benefit demonstrated relative to other available analgesics

  

  • PENTHROX has Marketing Authorisation in the emergency relief of moderate to severe pain associated with trauma in conscious adult patients.
  • Its analgesic superiority compared with placebo has been demonstrated in a study in patients with predominantly moderate pain.
  • Its efficacy in case of very severe pain (NS > 7 or VAS > 70) has not been evaluated.
  • No comparison of satisfactory methodological quality with other analgesics is available.

 

 


Clinical Added Value

no clinical added value

-


Therapeutic use

-

-

Contact Us

Évaluation des médicaments